4724-56-5Relevant articles and documents
Synthesis,18 F-Radiolabelling and Biological Characterization of Novel Fluoroalkylated Triazine Derivatives for in Vivo Imaging of Phosphodiesterase 2A in Brain via Positron Emission Tomography
Schr?der, Susann,Wenzel, Barbara,Deuther-Conrad, Winnie,Teodoro, Rodrigo,Egerland, Ute,Kranz, Mathias,Scheunemann, Matthias,H?fgen, Norbert,Steinbach, J?rg,Brust, Peter
, p. 9591 - 9615 (2015)
Phosphodiesterase 2A (PDE2A) is highly and specifically expressed in particular brain regions that are affected by neurological disorders and in certain tumors. Development of a specific PDE2A radioligand would enable molecular imaging of the PDE2A protei
Macrocyclic compound, and preparation method and application thereof
-
Paragraph 0209-0211, (2021/06/23)
The invention discloses a macrocyclic kinase inhibitor, and a compound, or a stereoisomer or a pharmaceutically acceptable salt thereof as shown in a formula (I). Experiments show that the novel compound shown in the formula (I) shows good TRK inhibitory
Aggregation-induced emission based on a fluorinated macrocycle: visualizing spontaneous and ultrafast solid-state molecular motions at room temperature: via F?F interactions
Guo, Jingjing,He, Zhanyu,Irfan, Majeed,Liu, Tingting,Zeng, Zhuo,Zhang, Mei,Zhao, Zujin
supporting information, p. 14919 - 14924 (2020/11/17)
We for the first time report the efficient construction of novel tetraphenethylene (TPE)-based macrocycles with various mechanofluorochromism (MFC) behaviors involving solid-state molecular motions. We were able to facilely regulate the diverse solid-stat
A compound for PET imaging and use thereof
-
Paragraph 0068-0070, (2018/04/21)
The present invention provides a precursor compound for the production of a radioactive compound for efficient contrast of the heart, a radioactive compound prepared using the precursor compound, and uses as a contrast medium for a PET contrast medium.br